Business ❯ Pharmaceuticals

Market Trends

Weight Loss Drugs Drug Development US Market Revenue Growth Pricing Strategies Company Acquisitions Vertical Integration Drug Patents China Competitor Analysis Product Launches Reshoring Acquisitions Patent Expirations Prescription Drugs Growth Cycles Biomanufacturing Consumer Demand Vaccine Sales Drug Supply Shortages Stock Listings Retail Pharmacy Drug Pricing Sales Forecasts Chronic Therapy Drug Pipeline Stock Performance Cost of Treatments Consumer Health Products Domestic Market

Novartis to Acquire Excellergy in Up to $2 Billion Deal for Next-Gen Anti-IgE

The move backs a design that strips IgE from immune cells to shut down allergic signaling faster.

Telix Confirms Webcast Investor Sessions at Oppenheimer and TD Cowen Conferences

Eli Lilly’s GLP-1 Lead Faces New Pressure From Novo’s Weight-Loss Pill

Amgen Buys Oxford Spinout Dark Blue Therapeutics for Up to $840 Million

Novartis Posts Q3 Sales Rise but Misses Views, Reaffirms 2025 Outlook

Pfizer Strikes U.S. Drug-Pricing Pact, Wins Exemption From 100% Import Tariff